University of Maryland, Center for Vaccine Development, School of Medicine


Our faculty and staff are experts in the field of global health and vaccinology, and they are dedicated to improving global health by conducting innovative, world-leading research in Baltimore and around the world. Our key mission is to harness the power of vaccines to prevent disease and save lives in the most vulnerable populations.

Our research, surveillance and vaccine development focuses on four key areas: Enteric Diseases, Malaria, Influenza and Respiratory Diseases, and Emerging Pathogens.

For over 40 years, our researchers in the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine (UMSOM) in Baltimore, MD have worked domestically and internationally to develop, test, and deploy vaccines to aid the world’s underserved populations.

The CVD is an academic enterprise engaged in the full range of infectious disease intervention from basic laboratory research through vaccine development, pre-clinical and clinical evaluation, large-scale pre-licensure field studies, and post-licensure assessments.

Training is a critical component of our work to ensure the foundation for the next generation of scientists and researchers committed to global health initiatives.


Originally formed in 1974 as the Center for Vaccine Development, our faculty has worked nationally and internationally to prevent diseases and save lives through the development and delivery of vaccines. As an academic research center, the Center has been engaged in the full range of vaccinology, including basic science research, vaccine development, antigen discovery, microbial pathogenesis, immunology, pre-clinical and clinical evaluation, and post-marketing field studies.‌‌

Learn more about our history and founding

Today, the Center’s work has been expanded beyond vaccine development to the broader goal of improving global health by conducting innovative, leading research in Baltimore and around the world and developing new and improved ways to diagnose, prevent, treat, control, and eradicate diseases of global impact. Currently, these diseases include malaria, typhoid, shigella and vaccine-preventable infectious diseases such as measles. Members of our faculty have been involved in critical vaccine development for emerging pathogens such as Zika and Ebola. In addition, our work focuses on the ever-growing challenge of anti-microbial resistance. Our researchers are uncovering ways to address the immune response to drug-resistant infections.